Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Cysteine proteinase inhib… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.

Artikel i vetenskaplig tidskrift
Författare Fredrik Strålberg
Petra Henning
Inger Gjertsson
Bert Kindlund
Pedro P C Souza
Emma Persson
Magnus Abrahamson
Franciszek Kasprzykowski
Anders Grubb
Ulf H Lerner
Publicerad i FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Volym 27
Nummer/häfte 7
Sidor 2687-701
ISSN 1530-6860
Publiceringsår 2013
Publicerad vid Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning
Centre for Bone and Arthritis Research
Sidor 2687-701
Språk en
Länkar dx.doi.org/10.1096/fj.12-211748
Ämnesord Animals, Antigens, CD14, metabolism, Blotting, Western, Bone Marrow Cells, cytology, drug effects, metabolism, Cell Differentiation, drug effects, Cells, Cultured, Cystatin C, pharmacology, Cysteine Proteinase Inhibitors, pharmacology, Gene Expression, drug effects, Humans, Macrophages, cytology, drug effects, metabolism, Mice, Mice, Inbred C57BL, Monocytes, cytology, drug effects, metabolism, NFATC Transcription Factors, genetics, metabolism, Osteoclasts, cytology, drug effects, metabolism, Proto-Oncogene Proteins c-fos, genetics, metabolism, RANK Ligand, pharmacology, Receptor Activator of Nuclear Factor-kappa B, metabolism, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, drug effects
Ämneskategorier Endokrinologi

Sammanfattning

The cysteine proteinase inhibitor cystatin C inhibited RANKL-stimulated osteoclast formation in mouse bone marrow macrophage cultures, an effect associated with decreased mRNA expression of Acp5, Calcr, Ctsk, Mmp9, Itgb3, and Atp6i, without effect on proliferation or apoptosis. The effects were concentration dependent with half-maximal inhibition at 0.3 μM. Cystatin C also inhibited osteoclast formation when RANKL-stimulated osteoclasts were cultured on bone, leading to decreased formation of resorption pits. RANKL-stimulated cells retained characteristics of phagocytotic macrophages when cotreated with cystatin C. Three other cysteine proteinase inhibitors, cystatin D, Z-RLVG-CHN2 (IC50 0.1 μM), and E-64 (IC50 3 μM), also inhibited osteoclast formation in RANKL-stimulated macrophages. In addition, cystatin C, Z-RLVG-CHN2, and E-64 inhibited osteoclastic differentiation of RANKL-stimulated CD14(+) human monocytes. The effect by cystatin C on differentiation of bone marrow macrophages was exerted at an early stage after RANKL stimulation and was associated with early (4 h) inhibition of c-Fos expression and decreased protein and nuclear translocation of c-Fos. Subsequently, p52, p65, IκBα, and Nfatc1 mRNA were decreased. Cystatin C was internalized in osteoclast progenitors, a process requiring RANKL stimulation. These data show that cystatin C inhibits osteoclast differentiation and formation by interfering intracellularly with signaling pathways downstream RANK.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?